Skip to main content
Erschienen in: AIDS and Behavior 6/2013

01.07.2013 | Original Paper

Feasibility, Acceptability and Preliminary Efficacy of an Online Peer-to-Peer Social Support ART Adherence Intervention

verfasst von: Keith J. Horvath, J. Michael Oakes, B. R. Simon Rosser, Gene Danilenko, Heather Vezina, K. Rivet Amico, Mark L. Williams, Jane Simoni

Erschienen in: AIDS and Behavior | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

This study describes the results of an online social support intervention, called “Thrive with Me” (TWM), to improve antiretroviral therapy (ART) adherence. HIV-positive gay or bisexually-identified men self-reporting imperfect ART adherence in the past month were randomized to receive usual care (n = 57) or the eight-week TWM intervention (n = 67). Self-reported ART outcome measures (0–100 % in the past month) were collected at baseline, post-intervention, and 1-month follow-up. Follow-up assessment completion rate was 90 %. Participants rated (1–7 scale) the intervention high in information and system quality and overall satisfaction (Means ≥ 5.0). The intervention showed modest effects for the overall sample. However, among current drug-using participants, the TWM (vs. Control) group reported significantly higher overall ART adherence (90.1 vs. 57.5 % at follow-up; difference = 31.1, p = 0.02) and ART taken correctly with food (81.6 vs. 55.7 % at follow-up; difference = 47.9, p = 0.01). The TWM intervention appeared feasible to implement, acceptable to users, and demonstrated greatest benefits for current drug users.
Literatur
1.
Zurück zum Zitat The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9.CrossRef The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9.CrossRef
2.
Zurück zum Zitat Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef
3.
Zurück zum Zitat Prejean J, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS One. 2011;6(8):e17502.PubMedCrossRef Prejean J, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS One. 2011;6(8):e17502.PubMedCrossRef
4.
Zurück zum Zitat Centers for Disease Control and Prevention, HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010, 2012. Centers for Disease Control and Prevention, HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010, 2012.
5.
Zurück zum Zitat Mills EJ, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCrossRef Mills EJ, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCrossRef
6.
Zurück zum Zitat Mugavero MJ, et al. Failure to establish HIV care: characterizing the “no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef Mugavero MJ, et al. Failure to establish HIV care: characterizing the “no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef
7.
Zurück zum Zitat Simoni J, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedCrossRef Simoni J, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedCrossRef
8.
Zurück zum Zitat Simoni J, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed Simoni J, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed
9.
Zurück zum Zitat Thompson MA, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRef Thompson MA, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRef
10.
Zurück zum Zitat Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011;6(11):e27533.PubMedCrossRef Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011;6(11):e27533.PubMedCrossRef
11.
Zurück zum Zitat Page TF, et al. A cost analysis of an internet-based medication adherence intervention for people living with HIV. J Acquir Immune Defic Syndr. 2012;60(1):1–4.PubMedCrossRef Page TF, et al. A cost analysis of an internet-based medication adherence intervention for people living with HIV. J Acquir Immune Defic Syndr. 2012;60(1):1–4.PubMedCrossRef
12.
Zurück zum Zitat Pellowski JA, Kalichman SC. Recent advances (2011–2012) in technology-delivered interventions for people living with HIV. Curr HIV/AIDS Rep. 2012;9(4):326–34.PubMedCrossRef Pellowski JA, Kalichman SC. Recent advances (2011–2012) in technology-delivered interventions for people living with HIV. Curr HIV/AIDS Rep. 2012;9(4):326–34.PubMedCrossRef
13.
Zurück zum Zitat Fisher JD, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows project. AIDS Behav. 2011;15(8):1635–46.PubMedCrossRef Fisher JD, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows project. AIDS Behav. 2011;15(8):1635–46.PubMedCrossRef
14.
Zurück zum Zitat Portnoy DB, et al. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47(1):3–16.PubMedCrossRef Portnoy DB, et al. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47(1):3–16.PubMedCrossRef
15.
Zurück zum Zitat Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23(1):107–15.PubMedCrossRef Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23(1):107–15.PubMedCrossRef
17.
Zurück zum Zitat Fox S. Peer-to-peer healthcare: many people-especially those living with chronic or rare diseases-use online connections to supplement professional medical advice. Washington DC: Pew Research Center’s Internet & American Life Project; 2011. Fox S. Peer-to-peer healthcare: many people-especially those living with chronic or rare diseases-use online connections to supplement professional medical advice. Washington DC: Pew Research Center’s Internet & American Life Project; 2011.
18.
Zurück zum Zitat Horvath K, et al. Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav. 2012;16(4):900–10.PubMedCrossRef Horvath K, et al. Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav. 2012;16(4):900–10.PubMedCrossRef
19.
Zurück zum Zitat Rosser BS, et al. Reducing HIV risk behavior of men who have sex with men through persuasive computing: results of the Men’s INTernet Study-II. AIDS. 2010;24(13):2099–107.PubMedCrossRef Rosser BS, et al. Reducing HIV risk behavior of men who have sex with men through persuasive computing: results of the Men’s INTernet Study-II. AIDS. 2010;24(13):2099–107.PubMedCrossRef
20.
Zurück zum Zitat Potosky D. The internet knowledge (iKnow) measure. Comput Hum Behav. 2007;23(6):2760–77.CrossRef Potosky D. The internet knowledge (iKnow) measure. Comput Hum Behav. 2007;23(6):2760–77.CrossRef
21.
Zurück zum Zitat Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1992;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1992;1:385–401.CrossRef
22.
Zurück zum Zitat Zhang W, et al. Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One. 2012;7(7):e40793.PubMedCrossRef Zhang W, et al. Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One. 2012;7(7):e40793.PubMedCrossRef
23.
Zurück zum Zitat Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.PubMedCrossRef Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.PubMedCrossRef
24.
Zurück zum Zitat Wong MD, et al. The association between life chaos, health care use, and health status among HIV-infected persons. J Gen Intern Med. 2007;22(9):1286–91.PubMedCrossRef Wong MD, et al. The association between life chaos, health care use, and health status among HIV-infected persons. J Gen Intern Med. 2007;22(9):1286–91.PubMedCrossRef
25.
Zurück zum Zitat Emlet CA. Measuring stigma in older and younger adults with HIV/AIDS: an analysis of an HIV stigma scale and initial exploration of subscales. Res Soc Work Pract. 2005;15:291–300.CrossRef Emlet CA. Measuring stigma in older and younger adults with HIV/AIDS: an analysis of an HIV stigma scale and initial exploration of subscales. Res Soc Work Pract. 2005;15:291–300.CrossRef
26.
Zurück zum Zitat Saunders JB, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804.PubMedCrossRef Saunders JB, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804.PubMedCrossRef
27.
Zurück zum Zitat DeLone WH, McLean ER. The DeLone and McLean model of information systems success: a ten-year update. J Manag Inf Syst. 2003;19(4):9–30. DeLone WH, McLean ER. The DeLone and McLean model of information systems success: a ten-year update. J Manag Inf Syst. 2003;19(4):9–30.
28.
Zurück zum Zitat DeLone WH, McLean ER. Information systems success: the quest for the dependent variable. Inf Syst Res. 1992;3(1):60–95.CrossRef DeLone WH, McLean ER. Information systems success: the quest for the dependent variable. Inf Syst Res. 1992;3(1):60–95.CrossRef
29.
Zurück zum Zitat Simoni J, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedCrossRef Simoni J, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedCrossRef
30.
Zurück zum Zitat Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.PubMedCrossRef Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.PubMedCrossRef
31.
Zurück zum Zitat Begg C, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–9.PubMedCrossRef Begg C, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–9.PubMedCrossRef
32.
Zurück zum Zitat Dimitrov DM, Rumrill PD Jr. Pretest-posttest designs and measurement of change. Work. 2003;20(2):159–65.PubMed Dimitrov DM, Rumrill PD Jr. Pretest-posttest designs and measurement of change. Work. 2003;20(2):159–65.PubMed
33.
Zurück zum Zitat Gottman JM, Rushe RH. The analysis of change: issues, fallacies, and new ideas. J Consult Clin Psychol. 1993;61(6):907–10.PubMedCrossRef Gottman JM, Rushe RH. The analysis of change: issues, fallacies, and new ideas. J Consult Clin Psychol. 1993;61(6):907–10.PubMedCrossRef
34.
Zurück zum Zitat Bangsberg DR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef Bangsberg DR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef
35.
Zurück zum Zitat Pasternak AO, et al. Modest non-adherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis. 2012;206(9):1443–52.PubMedCrossRef Pasternak AO, et al. Modest non-adherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis. 2012;206(9):1443–52.PubMedCrossRef
36.
Zurück zum Zitat Rivet Amico K, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a Research Synthesis of Trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef Rivet Amico K, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a Research Synthesis of Trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef
37.
Zurück zum Zitat Anderson PL, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedCrossRef Anderson PL, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedCrossRef
Metadaten
Titel
Feasibility, Acceptability and Preliminary Efficacy of an Online Peer-to-Peer Social Support ART Adherence Intervention
verfasst von
Keith J. Horvath
J. Michael Oakes
B. R. Simon Rosser
Gene Danilenko
Heather Vezina
K. Rivet Amico
Mark L. Williams
Jane Simoni
Publikationsdatum
01.07.2013
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 6/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0469-1

Weitere Artikel der Ausgabe 6/2013

AIDS and Behavior 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.